Search Results

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

• Authors : Tesi, Bianca; Robelius, Anna; Baskin, Berivan ...

Subjects: Medical and Health Sciences; Clinical Medicine; Cancer and Oncology

• Source: Clinical Cancer Research. 31(14):3062-3071

Record details

Comparison of the clinicopathological features in myeloproliferative or myelodysplastic neoplasms with SF3B1/JAK2, SF3B1/CALR, or SF3B1/MPL co-mutations.

• Authors : Shao, Richard¹ (AUTHOR); Wang, Le² (AUTHOR); Zhang, Hailing³ (AUTHOR)

• Source: Leukemia & Lymphoma. Dec2025, Vol. 66 Issue 13, p2518-2527. 10p.

Record details

Correlation of EZH2 and related signaling molecules p-STAT3, p-ERK1/2, and MYC overexpression with H3K27 trimethylation associates differently to disease progression in JAK2 mutation -positive and -negative myeloid neoplasms.

• Authors : Flerova, Elizaveta^1,2 (AUTHOR); Chai, Jiani³ (AUTHOR); Choudhuri, Jui ⁴ (AUTHOR)

• Source: Leukemia & Lymphoma. Dec2025, p1-14. 14p. 7 Illustrations.

Record details

Beyond germ cell tumors: focus on Leydig cell neoplasms from a single-center experience.

• Authors : Leonardi R; Department of Medicine and Surgery, University KORE of Enna; Casa di Cura Musumeci GECAS, Gravina di Catania (CT).

Subjects: Leydig Cell Tumor*/Leydig Cell Tumor*/Leydig Cell Tumor*/diagnosis ; Leydig Cell Tumor*/Leydig Cell Tumor*/Leydig Cell Tumor*/pathology ; Leydig Cell Tumor*/Leydig Cell Tumor*/Leydig Cell Tumor*/surgery

• Source: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2025 Sep 30; Vol. 97 (3), pp. 13978. Publisher: PagePress Country of Publication: Italy NLM ID: 9308247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2282-4197

Record details

Adverse outcomes and high incidence of therapy-related neoplasms in patients with the t(16;21)/RUNX1::RUNX1T3 fusion.

• Authors : Guo, Dongmei¹ (AUTHOR); Wang, Cui² (AUTHOR); Yao, Jingya² (AUTHOR)

• Source: Leukemia & Lymphoma. Dec2025, p1-8. 8p. 4 Illustrations.

Record details

Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms.

• Authors : Christen, Matthias^1,2 (AUTHOR); Kaderli, Domenic^1,2 (AUTHOR); Ratknic, Milos¹ (AUTHOR)

• Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p128. 12p.

Record details

Interferon alpha in myeloproliferative neoplasms: evidence and practical considerations for clinical care.

• Authors : Metzger, Megan¹ (AUTHOR); Mascarenhas, John¹ (AUTHOR)

• Source: Leukemia & Lymphoma. Dec2025, p1-23. 23p.

Record details

Predictors of Symptom Scores in Myeloproliferative Neoplasms: A Real‐World Retrospective Cohort Study.

• Authors : Khan, Muhammad Ali¹ (AUTHOR); Naqvi, Syed Arsalan Ahmed¹ (AUTHOR); Camoriano, John K.¹ (AUTHOR)

• Source: Cancer Medicine. Dec2025, Vol. 14 Issue 23, p1-10. 10p.

Record details

The Impact of ASXL1 Gene Mutations on Clinical Course and Prognosis in Myeloproliferative Neoplasms.

• Authors : Uslu, Neslihan¹ ; Hancer, Veysel Sabri²; Kucukkaya, Reyhan Diz³

• Source: European Archives of Medical Research. Sep2025, Vol. 41 Issue 3, p154-162. 9p.

Record details

Intersecting Pathways: The Impact of Philadelphia-Negative Chronic Myeloproliferative Neoplasms on the Pathogenesis and Progression of Heart Failure with Preserved Ejection Fraction.

• Authors : Mihăilă, Marius-Dragoș¹ (AUTHOR); Caloian, Bogdan^1,2 (AUTHOR); Frîngu, Florina Iulia^1,2,3 (AUTHOR)

• Source: Diagnostics (2075-4418). Aug2025, Vol. 15 Issue 16, p2042. 18p.

Record details